Literature DB >> 3962169

Effects of cyclosporin A administration in cats.

K S Latimer, P M Rakich, B J Purswell, I M Kircher.   

Abstract

Cyclosporin A was administered orally to 10 cats for 28 consecutive days at a dosage of 20 mg/kg body weight daily divided into 2 equal doses. Serum trough CyA concentrations ranged from 134 to 902 ng/ml with a mean of 567 +/- 249 ng/ml (means +/- SD). Immunosuppression by CyA was suggested in 5 cats by significantly depressed lymphoblast transformation responses. Various hematologic, serum chemical, and urinalysis parameters were monitored on a weekly basis in 10 cats. Serum urea nitrogen concentration increased significantly from baseline values on days 7, 14, and 21, but not on day 28. Urine concentrating ability was unimpaired. Alanine aminotransferase activity was decreased significantly from baseline values at each sample period during CyA administration. Drug-related side effects were minor; one cat developed gingival hypertrophy which regressed within 21 days of CyA withdrawal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962169     DOI: 10.1016/0165-2427(86)90095-4

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

1.  Oxodipine-induced gingival hyperplasia in beagle dogs.

Authors:  A Nyska; T Waner; A Zlotogorski; M Pirak; M Scolnik; M Nyska; A Galiano
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 2.  Vaccination of Immunocompromised Cats.

Authors:  Katrin Hartmann; Karin Möstl; Albert Lloret; Etienne Thiry; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Regina Hofmann-Lehmann; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

3.  Polarization microscopy of picrosirius red-stained collagen from oxodipine-induced hyperplastic gingiva of beagle dogs.

Authors:  D Dayan; T Waner; H Tal; A Nyska
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.